undamentalytics Newsletter
Sign in

Camp4 Therapeutics Corp balance sheet

At the end of fiscal 2025, Camp4 Therapeutics Corp had total assets of $118m, total liabilities of $70.1m and shareholders' equity of $47.7m. It held $110m in cash against $0 of debt: net cash of $110m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents386411086
Total current assets406611490
Total assets557811893
Accounts payable1101
Deferred revenue (current)00913
Total current liabilities8101619
Total debt0000
Total liabilities17157094
Shareholders' equity−1246348−1
Non-controlling interests and other (assets − liabilities − equity)162———
Net debt (negative = net cash)−38−64−110−86
Shares outstanding———52m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CAMP vs CRISCAMP vs ENSCCAMP vs OCGNCAMP vs DBVT

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Camp4 Therapeutics Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Camp4 Therapeutics Corp.